Ann Lab Med.  2019 Jul;39(4):411-413. 10.3343/alm.2019.39.4.411.

A Multiplex Phytosterol Assay Utilizing Gas Chromatography-Mass Spectrometry for Diagnosis of Inherited Lipid Storage Disorders

Affiliations
  • 1Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea. songjhcp@snu.ac.kr
  • 2Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.
  • 3Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 4Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.

Abstract

No abstract available.


MeSH Terms

Diagnosis*
Gas Chromatography-Mass Spectrometry*

Figure

  • Fig. 1 Comparison of phytosterol levels between NCs (N=18) and patients with CTX (N=5) and sitosterolemia (N=4). The outer horizontal lines at both ends depict the upper and lower quartile values, and the middle horizontal line depicts the median. P value was calculated using the Mann–Whitney U test.Abbreviations: NC, normal control; CTX, cerebrotendinous xanthomatosis.


Reference

1. Kuriyama M, Fujiyama J, Kasama T, Osame M. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis. J Lipid Res. 1991; 32:223–229. PMID: 2066659.
2. Yoo EG. Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management. Ann Pediatr Endocrinol Metab. 2016; 21:7–14. PMID: 27104173.
3. Kidambi S, Patel SB. Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis. J Clin Pathol. 2008; 61:588–594. PMID: 18441155.
4. Escola-Gil JC, Quesada H, Julve J, Martin-Campos JM, Cedo L, Blanco-Vaca F. Sitosterolemia: diagnosis, investigation, and management. Curr Atheroscler Rep. 2014; 16:424. PMID: 24821603.
5. CSLI. CLSI document EP06-A. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. Wayne, PA: Clinical and Laboratory Standards Institute;2003.
6. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003; 75:3019–3030. PMID: 12964746.
7. Lorincz MT, Rainier S, Thomas D, Fink JK. Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. Arch Neurol. 2005; 62:1459–1463. PMID: 16157755.
8. Patel SB. Sitosterolemia and other rare sterol disorders. In : Garg A, editor. Dyslipidemias: pathophysiology, evaluation and management. 1st ed. New York: Humana Press;2015. p. 235–250.
9. Lee MH, Lu K, Patel SB. Genetic basis of sitosterolemia. Curr Opin Lipidol. 2001; 12:141–149. PMID: 11264985.
10. Park JH, Chung IH, Kim DH, Choi MH, Garg A, Yoo EG. Sitosterolemia presenting with severe hypercholesterolemia and intertriginous xanthomas in a breastfed infant: case report and brief review. J Clin Endocrinol Metab. 2014; 99:1512–1518. PMID: 24423340.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr